130 related articles for article (PubMed ID: 12513914)
1. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma.
Miles SA; Testa M; Huang J; Wade M; Carden J; Scadden DT
J Interferon Cytokine Res; 2002 Nov; 22(11):1143-8. PubMed ID: 12513914
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
[TBL] [Abstract][Full Text] [Related]
3. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
6. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
8. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile of HIV-positive Kaposi's sarcoma derived cells in vitro.
Brockmeyer NH; Willers CP; Anders S; Mertins L; Rockstroh JK; Stürzl M
Eur J Med Res; 1999 Mar; 4(3):95-100. PubMed ID: 10085275
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
[TBL] [Abstract][Full Text] [Related]
13. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.
Koon HB; Krown SE; Lee JY; Honda K; Rapisuwon S; Wang Z; Aboulafia D; Reid EG; Rudek MA; Dezube BJ; Noy A
J Clin Oncol; 2014 Feb; 32(5):402-8. PubMed ID: 24378417
[TBL] [Abstract][Full Text] [Related]
15. Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity.
Bernstein ZP; Porter MM; Gould M; Lipman B; Bluman EM; Stewart CC; Hewitt RG; Fyfe G; Poiesz B; Caligiuri MA
Blood; 1995 Nov; 86(9):3287-94. PubMed ID: 7579429
[TBL] [Abstract][Full Text] [Related]
16. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma.
Pluda JM; Shay LE; Foli A; Tannenbaum S; Cohen PJ; Goldspiel BR; Adamo D; Cooper MR; Broder S; Yarchoan R
J Natl Cancer Inst; 1993 Oct; 85(19):1585-92. PubMed ID: 7692072
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J
J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study.
Krown SE; Li P; Von Roenn JH; Paredes J; Huang J; Testa MA
J Interferon Cytokine Res; 2002 Mar; 22(3):295-303. PubMed ID: 12034036
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
20. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]